A number of recent studies of aging in Drosophila, mice and dogs have shown an association between reduced body size and increased lifespan. It is unclear (a) whether such an association is a general feature of animal species; and (b) whether the association reflects an effect of body size on aging, or pleiotropic effects of common determinants of growth and aging. To address these issues, we have studied the relationship between size and lifespan in the nematode Caenorhabditis elegans, and surveyed related findings in Drosophila. In C. elegans, we compared 12 wild isolates with varying body size and lifespan, but saw no correspondence between these traits. We also examined aging in giant and dwarf mutants, but observed only reduced lifespan in all cases. In a comparison of 15 long-lived daf-2 insulin/IGF receptor mutants, we saw a positive correlation between body length and lifespan, and up to a 28% increase in daf-2 mutant body volume. Thus, in C. elegans, insulin/IGF signaling may limit growth rather than promote it. Studies of Drosophila show no consistent correlation between body size and lifespan. These results indicate that the negative correlation between body size and lifespan seen in some mammals is not typical of invertebrates, but support the view that co-variation of size and longevity may occur via effects on insulin/IGF signaling. q
Introduction
Interventions such as dietary restriction (Masoro, 1995 (Masoro, , 2000 , gene mutation (Kenyon, 2001 ) and removal of the germline (Hsin and Kenyon, 1999) reduce the rate of aging in some model organisms, but how they do so remains unclear. Clues to the mechanisms of aging may be obtained by looking for correlated responses to such treatments. One such correlated trait identified in a number of recent studies is reduced body size. Lifespan increases have been observed in mouse lines selected for reductions in body size (Roberts, 1961; Eklund and Bradford, 1977; Miller et al., 2000) . Moreover, a number of dwarf mouse mutants have recently been shown to have increased lifespan (Brown-Borg et al., 1996; Coschigano et al., 2000; Flurkey et al., 2001 ). An inverse relationship between body size and lifespan has also been reported between breeds of domestic dog (Michell, 1999) . In Drosophila melanogaster, two longlived dwarf mutants have also been identified (Clancy et al., 2001; Tatar et al., 2001) . Such an association between size and longevity within species is the opposite of that seen between species (mammals in particular), where larger animal species tend to be longer lived (with notable exceptions) (Promislow, 1993) .
Why might smaller individuals live longer? Either a smaller body size results in greater longevity, or growth and longevity share common determinants. One candidate for a determinant of body size and longevity is the growth hormone/insulin-like growth factor I (IGF-I) axis (or somatotropic axis) in mammals, and the homologous insulin/IGF signaling (IIS) pathway in invertebrates (reviewed in Bartke, 2000; Gems and Partridge, 2001) .
We have examined the relationship between body size, IIS and lifespan in the nematode Caenorhabditis elegans, and reviewed related findings in Drosophila. Our aims were (1) to establish whether reduced body size is generally associated with increased lifespan, and (2) whether IIS promotes increased body size in C. elegans as it does in mammals and in Drosophila (Weinkove and Leevers, 2000) . To this end, we measured body size and lifespan in (a) 12 wild isolates of C. elegans which exhibit differences in body size and lifespan; (b) giant and dwarf C. elegans mutants; and (c) 15 daf-2 insulin/IGF receptor mutants exhibiting varying degrees of extended lifespan. Our results show that a) in C. elegans, as in Drosophila, there is no clear general effect of body size on lifespan; and b), as in Drosophila, IIS has a role in the determination of adult body size. Surprisingly, though, in C. elegans IIS retards rather than promotes growth.
Materials and methods

Stocks and culture methods
The C. elegans wild isolates studied (Table 1) are described by Hodgkin and Doniach (1997) . The body size mutants used were as follows. Giants: CB185 lon-1 (e185) III, CB678 lon-2(e678) X and MT3847 lon-2(n1630) X. Dwarves: CB30 sma-1(e30) V, CB491 sma-3 (e491) III, DR1369 sma-4(e729) III, CB88 dpy-7(e88) X, CB128 dpy-10(e128) II and CB184 dpy-13(e184) IV. The daf-2 alleles employed were e979, e1365, e1368, e1369, e1370, e1371, e1391, m41, m120, m212, m577, m579, m596, sa193 and sa223. For further description of these alleles see Gems et al. (1998) . The N2 wild type used was the Caenorhabditis Genetics Center male stock (CGCM). All daf-2 mutant strains were back-crossed at least 3 times to N2 CGCM, to remove second site mutations and to reduce possible confounding effects due to variation in the genetic background of the N2 wild type (Gems and Riddle, 2000) .
Nematodes were maintained on 60 mm Petri dishes on NGM agar, with E. coli OP50 as a food source (Brenner, 1974) , except in the study of wild isolates, where worms were maintained in liquid culture. Liquid culture medium consisted of E. coli in S medium (Sulston and Hodgkin, 1988) . Worms were kept singly in 96-well microtitre plates (U wells) under 50 ml of culture medium.
Body size measurements
To record body lengths and widths, worms were placed on agar plates and killed by heating the nearby agar with a hot scalpel. To facilitate measurement, animals were laid out straight using a platinum wire. Measurements were made using a dissecting microscope, with an eyepiece graticule calibrated with a stage micrometer. To calculate body volume, worms were treated as cylinders ðv ¼ pr 2 lÞ: After moulting to the adult, C. elegans hermaphrodites continue to grow for several days (Byerly et al., 1976) . In the case of wild isolates, giant and dwarf mutants, and selected daf-2 mutants, body size was measured during the first 3 days of adulthood and maximum size recorded. In the comparison of 15 daf-2 alleles, one day-old adults were measured.
Lifespan measurements
These were performed as previously described (Gems et al., 1998) , except that in some cases monoxenic liquid culture was used (see above). Lifespan and body length measurements were made at the same time and temperature within each trial, apart from the IIS mutants, where growth curves for selected strains were performed after the lifespan measurements (see Section 3).
Statistical methods
Median rather than mean lifespans were calculated since typical age-specific death frequencies do not show a normal distribution. For wild isolate and body size mutant trials, survival data were re-sampled 50,000 times using R software (www.r-project.org) to obtain a mean of median values across replicates, and the 95% confidence limits around them. Survival analyses were performed using the Kaplan-Meier method. Differences in mean body size within trials were analysed using analysis of variance, and statistical comparisons for pairs of means performed using a Tukey-Kramer honestly significant difference test. Correlation analyses were carried out for lifespan against body length, width or volume. Statistical software used was JMP v.3 (SAS Institute Inc.).
Results
Body size and lifespan in wild isolates
To ask whether body size per se determines lifespan we examined the relationship between naturally occurring variation in body size and longevity in 12 C. elegans wild isolates from around the world (Hodgkin and Doniach, 1997) (Table 1 ). Although we saw significant variation in body length (P , 0.001) and lifespan (P , 0.001), there was no significant correlation between lifespan and body length ( Fig. 1(a) and (b)).
Aging in giant and dwarf mutants
We also asked whether mutations that increase or decrease body size result in correlated effects on aging. A major regulatory pathway for body size in C. elegans involves the TGFb-like ligand DBL-1, signaling via the DAF-4 and SMA-6 TGFb receptors and the SMA-2, SMA-3 and SMA-4 SMAD proteins (reviewed in Savage-Dunn (2001) . Mutations in these components result in reduced body size, apparently due to a reduction in cell size rather than in cell number (Suzuki et al., 1999; Flemming et al., 2000) . Mutations in lon (long) genes result in giant adults that exhibit an increased body length. LON-1 is a protein of unknown biochemical function whose expression is regulated by DBL-1 (Morita et al., 2002) . We examined mutants affected in sma-1, sma-3, lon-1 and lon-2. Another class of genes affecting body size and morphology are the dpy (dumpy) genes. Dpy mutants are short and fat, and in many cases the genes involved encode cuticle collagens, including those examined here: dpy-7, dpy-10 and dpy-13 (von Mende et al., 1988; Johnstone et al., 1992; Levy et al., 1993) .
If there were a general correlation between small size and longevity, then we would expect giant Lon mutants to be short lived, and dwarf Sma and Dpy mutants to be long lived. All strains had body lengths significantly different from N2. In both the large and the small mutants the median lifespan was significantly reduced relative to N2. Maximum lifespan was also decreased in all mutants but lon-1(e678), and sma-3(e491) where it was increased. (Table 2) . However, these mutants displayed a range of deleterious effects to various extents, including high incidences of death due to internal hatching of eggs, and extrusion of the gonad through the vulva. Moreover, in many cases, in mid-life and beyond animals appeared pale and/or shrivelled relative to wild type. It is therefore possible that the short lifespans of these strains is due to deleterious pleiotropic effects of the mutations they bear, masking any potential effect of body size on lifespan.
Body size and lifespan in IIS mutants
In C. elegans, mutations affecting a number of genes in an insulin/IGF signaling (IIS) pathway increase lifespan. This pathway is regulated via daf-2, which encodes a receptor tyrosine kinase similar to the mammalian insulin and IGF-1 receptors (Kenyon et al., 1993; Kimura et al., 1997) . In contrast to the case of long-lived mice with mutations affecting the somatotropic axis (Brown-Borg et al., 1996; Coschigano et al., 2000; Flurkey et al., 2001) , and IIS mutant Drosophila (Clancy et al., 2001; Tatar et al., 2001) , no alteration of adult body size has been reported in IIS mutant C. elegans. However, IIS mutations can affect larval body size by causing constitutive formation of the thin-bodied, diapausal dauer larva form (Riddle et al., 1997) .
Hermaphrodite lifespan and body length was measured in 15 mutants bearing reduction-of-function alleles of daf-2. The effect of many of these mutations on lifespan is temperature sensitive, and the study was carried out at 15 8C, where median lifespan increases relative to wild type ranged from 8 to 120% (Gems et al., 1998) . We observed a significant positive correlation between daf-2 mutant body length and both median and maximum lifespan (Table 3) (Fig. 1(c) and (d) ). However, no significant correlations were found between body width and median or maximum lifespan (correlation: 2 0.425, P ¼ 0.114 and 2 0.412, P ¼ 0.127, respectively), or between mean body volume and either median or maximum lifespan (correlation: 2 0.198, P ¼ 0.480, and 2 0.141, P ¼ 0.617, respectively). Body lengths in all daf-2 mutants were significantly greater than wild type, except for e1365, e1368, m41, m577, m579 and sa193 (TukeyKramer test).
C. elegans adults continue to grow for the first few days of adulthood. As body size was measured in 1-dayold adults, it is possible that any potential positive correlation between body length and lifespan resulted from an accelerated growth rate in daf-2 mutants, rather than increased final body size. We therefore measured body size in daf-2(e979), daf-2(e1370) and daf-2(m41), during the first 3 days of adulthood at 15 8C. At this temperature only the e979 and e1370 alleles cause marked increases in lifespan. m41, e979 and e1370 all resulted in a significant increase in adult body length over N2, and e1370 in a significant increase of 28% in adult body volume (Fig. 2) . The fact that daf-2(e979) was not larger in volume than wild type despite being longer was due to its reduced body width: the width of 3-day old e979 adults was 6.0% of their length, compared to 6.6% in N2 adults of the same age. Taken together, these results indicate that wild-type insulin/IGF signaling acts to reduce adult body size. (Gems et al., 1998) . Twelve animals were measured for each allele. Alleles are in order of increasing severity of the dauer constitutive phenotype.
a Progeny of daf-2(sa223)/qC1 [dpy-19(e1259ts) glp-1(q339) ] hermaphrodites. 
Discussion
Body size and lifespan in C. elegans
We have examined the relationship between body size and lifespan in a range of C. elegans strains. Comparing variation in naturally occurring C. elegans isolates we found that there is no effect of body size on longevity. Moreover, dwarf Sma and Dpy mutants as well as giant Lon mutants were short lived. Previously, extended lifespan was not seen in a daf-4 dwarf mutant (Larsen et al., 1995) . However, it is possible that the effects of retarded aging on lifespan in Dpy and Sma mutants were masked by deleterious pleiotropic effects. The increase in sma-3 mutant maximum lifespan is consistent with this.
We also examined body size in 15 daf-2 IIS mutants, exhibiting a range of severities of the extended lifespan trait.
There was a significant positive correlation between body length and lifespan, and of three alleles tested further, one, daf-2(e1370), resulted in increased body volume. Thus, in C. elegans, wild type IIS can act to limit body size. However, a more severe loss-of-function allele, e979, resulted in increased body length but reduced body diameter. This suggests a possible non-linear effect of IIS levels on body size. Thus, moderate reductions in IIS (as in e1370 ) may result in proportional increases in both length and diameter, while severe reductions in IIS (as in e979 ) may result in increases in body length, but reduction in body width. Possibly e979 mutants are thin as the result of partial expression of dauer larva-like morphology. The mechanism of action of IIS on body size remains to be investigated. DBL-1 TGFb signaling promotes growth by stimulating endoreduplication of hypodermal nuclei (Flemming et al., 2000) . Possibly there is cross talk between IIS and DBL-1 TGFb signaling, as there is between IIS and DAF-7 TGFb signaling in the regulation of dauer larva formation (Ogg et al., 1997) .
The effect of IIS on body size in C. elegans described here differs from that in other organisms. For example, in Drosophila, mutation of Inr, which encodes an insulin/IGF receptor, results in retarded development, and dwarf adults (Chen et al., 1996) . In mammals, disruption of somatotropic signaling, where circulating IGF-1 levels are reduced, leads to reduced body size (Sara and Hall, 1990; Jones and Clemmons, 1995) . Why might the role of IIS in the regulation of body size in C. elegans be reversed?
One clue is that overexpression of INS-1, the C. elegans insulin-like peptide that best resembles mammalian insulin, appears to antagonise signaling from the DAF-2 receptor (Pierce et al., 2001) . From this it was suggested that the function of the DAF-2 receptor might be reversed relative to the mammalian insulin receptor, such that ligand binding blocks receptor activation rather than potentiating it. Thus, perhaps INS-1 promotes growth by inhibiting DAF-2 action. A further possibility is that the action of IIS on body size is germline dependent. Like mutation of daf-2, removal of the germline by ablation of germline precursor cells using a laser microbeam results in increased body volume (up to 46%) (Patel et al., 2002) , and increased longevity (Hsin and Kenyon, 1999) . However, while the effects of both daf-2 and germline signaling on lifespan require the activity of the forkhead transcription factor DAF-16 (Kenyon et al., 1993; Hsin and Kenyon, 1999) , this is not true of the effect of the germline on body size (Patel et al., 2002) .
Overall, these results are consistent with the view that correlations between body size and lifespan occur as a consequence of the effect of insulin/IGF signaling on these two traits. Thus, the lack of any correlation between body size and longevity seen in the study of C. elegans wild isolate strains may reflect the fact that neither body size or lifespan variation in these strains is the result of variation in IIS levels. 
Body size and lifespan in Drosophila
The absence of a general correspondence between small body size and increased lifespan in C. elegans is consistent with results in Drosophila. Several studies have noted a positive phenotypic correlation between Drosophila body size and lifespan Farquhar, 1981, 1983; Partridge et al., 1986) , while genetic correlations between these traits have been either positive (Tantawy and Rakha, 1964; Tantawy and el-Helw, 1966; Partridge and Fowler, 1992) , or have not been detected (Zwaan et al., 1995) .
Several studies have examined the effect of varying body size on longevity, or vice versa. Early comparisons of longand short-lived lines resulting from selection for late and early fecundity, respectively, saw no correlated changes in body size (Rose, 1984; Luckinbill et al., 1988) . In these studies body weight was measured at least two days after eclosion. In a later study involving two sets of lines selected for early and late fecundity, body size (thorax length, and wet weight) was measured shortly after eclosion (Partridge and Fowler, 1992) . Here, both sexes of longer-lived flies were larger in one set of lines (e.g. a 10% increase in weight in long-lived females). In the other set of selected lines, only males were significantly larger. Lifespan was measured in virgin flies. The long-lived flies also grew more slowly, potentially reflecting a greater resource investment into determinants of somatic durability. However, subsequent selection experiments of this type have not resulted in correlated changes in body size (Partridge et al., 1999) .
Longevity has also been examined in Drosophila lines with increased or reduced body size. For example, in female D. pseudoobscura, larger females are longer-lived, and also lay more eggs than smaller females (Tantawy and Vetukhiv, 1960; Tantawy, 1961) . It has also been shown that Drosophila evolves a larger body size in response to colder environments. These large lines are longer-lived than small and control lines, but only when survival analyses are performed at the cold temperatures at which the large lines were originally selected (McCabe and Partridge, 1997) . The larger lines also display increased daily progeny production, again, only at the cold temperature. Thus, selecting for larger size in Drosophila by raising lines at low temperature increases female performance in terms of survival and lifetime reproduction at low temperatures.
Why larger flies should be longer-lived is still poorly understood. The authors of the temperature selection experiments point out that it is unlikely to be increased desiccation resistance, since the increased lifespan and fecundity are only seen at lower temperatures where desiccation is less of a problem. They suggest that larger flies have an improved ability to acquire, conserve and use resources.
Bigger flies that are heavier because they contain more fat are starvation resistant, and this may also affect longevity (Zwaan et al., 1991) . One study of D. melanogaster examined longevity and fertility in large and small fly lines, raised on rich and poor food (Hillesheim and Stearns, 1992) . In the case of virgin flies, no difference in longevity was seen on rich food, while on poor food, large males lived longer, but larger females were shorter lived. In the case of mated females, lifespan in the larger flies was reduced by 34% under both food regimens. However, in Drosophila, egg production greatly reduces lifespan (Maynard Smith, 1958; Lamb, 1964; Partridge et al., 1987) , and larger females, with larger ovaries, laid more eggs early in life, and may have died sooner for this reason (Hillesheim and Stearns, 1992) .
Studies involving specific mutations that increase lifespan provide little evidence for a determining effect of body size on lifespan in Drosophila. Mutations affecting Inr (equivalent to C. elegans daf-2 ) and chico, which encodes an insulin receptor substrate protein, can result in long-lived dwarf flies (Clancy et al., 2001; Tatar et al., 2001 ). However, chico 1 / þ heterozygote females are not dwarf yet show up to a 36% increase in mean lifespan. Thus, the body size reduction is not required for the increase in lifespan (Clancy et al., 2001) .
In summary, these results show that in Drosophila there is no general negative correlation between body size and longevity. Selection for increased size can result in increased lifespan in Drosophila under specific conditions; however, selection for increased longevity does not result in increased body size. Body size mutants studied to date have shown a separation of the body size and longevity phenotypes.
Conclusions
The findings described here do not support the existence of a general relationship between body size and longevity in animal species, and show that in invertebrates such as C. elegans and Drosophila, correlated effects on body size and aging may only occur via IIS-associated pleiotropy. It has been suggested that reduced body size may lead to increased lifespan in mammals, for example by conserving cell proliferative capacity, or reducing the number of sites at which carcinogenesis can occur (reviewed in Bartke (2000) ). In this context, it may be significant that in both C. elegans and Drosophila, aging occurs in the absence of somatic cell proliferation. Thus, in the case of mammals, it remains equally possible that body size does directly affect aging, or that it is a pleiotropic correlate of IIS activity that also affects aging, or both.
